1. Home
  2. SPOT vs BMY Comparison

SPOT vs BMY Comparison

Compare SPOT & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOT
  • BMY
  • Stock Information
  • Founded
  • SPOT 2006
  • BMY 1887
  • Country
  • SPOT Luxembourg
  • BMY United States
  • Employees
  • SPOT N/A
  • BMY N/A
  • Industry
  • SPOT Broadcasting
  • BMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPOT Consumer Discretionary
  • BMY Health Care
  • Exchange
  • SPOT Nasdaq
  • BMY Nasdaq
  • Market Cap
  • SPOT 131.0B
  • BMY 120.5B
  • IPO Year
  • SPOT 2018
  • BMY N/A
  • Fundamental
  • Price
  • SPOT $574.25
  • BMY $49.23
  • Analyst Decision
  • SPOT Buy
  • BMY Hold
  • Analyst Count
  • SPOT 29
  • BMY 15
  • Target Price
  • SPOT $562.82
  • BMY $57.79
  • AVG Volume (30 Days)
  • SPOT 2.5M
  • BMY 14.6M
  • Earning Date
  • SPOT 04-29-2025
  • BMY 04-24-2025
  • Dividend Yield
  • SPOT N/A
  • BMY 5.04%
  • EPS Growth
  • SPOT N/A
  • BMY N/A
  • EPS
  • SPOT 5.69
  • BMY N/A
  • Revenue
  • SPOT $16,226,317,429.00
  • BMY $48,300,000,000.00
  • Revenue This Year
  • SPOT $18.23
  • BMY N/A
  • Revenue Next Year
  • SPOT $15.48
  • BMY N/A
  • P/E Ratio
  • SPOT $100.85
  • BMY N/A
  • Revenue Growth
  • SPOT 18.31
  • BMY 7.32
  • 52 Week Low
  • SPOT $267.76
  • BMY $39.35
  • 52 Week High
  • SPOT $652.63
  • BMY $63.33
  • Technical
  • Relative Strength Index (RSI)
  • SPOT 53.20
  • BMY 25.85
  • Support Level
  • SPOT $539.66
  • BMY $48.84
  • Resistance Level
  • SPOT $577.81
  • BMY $51.60
  • Average True Range (ATR)
  • SPOT 35.08
  • BMY 2.35
  • MACD
  • SPOT 3.06
  • BMY -0.84
  • Stochastic Oscillator
  • SPOT 95.49
  • BMY 3.20

About SPOT Spotify Technology S.A.

Spotify is the leading global music streaming service provider, with nearly 700 million monthly active users and over 250 million paying subscribers, with the latter comprising the firm's premium segment. most of the firm's revenue and nearly all its gross profit come from the subscribers, who pay a monthly fee to access a very comprehensive music library that consists of most of the most popular songs ever recorded, including all from the major record labels. The firm also sells separate audiobook subscriptions and integrates podcasts within its standard music app. Podcast content is not exclusive and is typically free to access on other platforms. Ad-supported users can access a similar music catalog but cannot customize a similar on-demand experience.

About BMY Bristol-Myers Squibb Company

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: